Albireo Pharma Inc
ALBO
ALBO was delisted on the 2nd of March, 2023.
41 hedge funds and large institutions have $32.9M invested in Albireo Pharma Inc in 2013 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 11 closing their positions.
171% more call options, than puts
Call options by funds: $2.84M | Put options by funds: $1.05M
86% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 7
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
2% less funds holding
Funds holding: 42 → 41 (-1)
31% less capital invested
Capital invested by funds: $47.8M → $32.9M (-$14.9M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$2.78M |
| 2 |
BC
Broadfin Capital
New York
|
+$2.34M |
| 3 |
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
|
+$2.06M |
| 4 |
FNYS
First New York Securities
New York
|
+$1.06M |
| 5 |
Millennium Management
New York
|
+$626K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$7.78M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$1.13M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$1.12M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$961K |
| 5 |
VM
VHCP Management
New York
|
-$715K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$1K | -9 | Closed |
|
52
Barclays
London,
United Kingdom
| – | -$391 | -3 | Closed |
|
ALBO Hedge Fund Activity: Q3 2013 in Review
41 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q3 2013, worth a combined $32.9M — down 31% from $47.8M a quarter earlier.
Fund positioning in ALBO was balanced in Q3 2013: 11 funds opened new positions, 11 closed out, 13 added to existing stakes and 7 trimmed.
The largest buyer was Numeric Investors, opening a new position worth an estimated $2.78M. The largest seller was OrbiMed, cutting an estimated $7.78M.
- 41 institutional investors held Albireo Pharma Inc (ALBO) as of Q3 2013, down from 42 in Q2 2013.
- Funds reported $32.9M of Albireo Pharma Inc stock for Q3 2013, down 31% quarter-over-quarter.
- 11 funds opened new Albireo Pharma Inc positions in Q3 2013 and 11 closed out, a net change of 0 holders.
- The largest Albireo Pharma Inc buyer in Q3 2013 was Numeric Investors, an estimated $2.78M added.
- The largest Albireo Pharma Inc seller in Q3 2013 was OrbiMed, an estimated $7.78M sold.
Based on aggregated 13F filings for Q3 2013.